Evidence-Based Medicine and the Selection of Lipid-Lowering Therapy in Type 2 Diabetes

被引：0

作者：

Carlos A. Aguilar-Salinas

Roopa Mehta

Rita A. Gomez-Diaz

机构：

[1] Instituto Nacional de Ciencias Medicas y Nutricion,Departamento de Endocrinologia y Metabolismo

[2] Instituto Mexicano del Seguro Social (IMSS),Unidad de Investigación Médica en Epidemiología Clínica, Centro Médico Nacional Siglo XXI

来源：

Current Diabetes Reports | 2012年 / 12卷

关键词：

Type 2 diabetes; Evidence-based medicine; Lipid-lowering therapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：221 / 223

页数：2

共 50 条

[21] Lipid-lowering therapy protects against peripheral sensory neuropathy in type 2 diabetes
Davis, Timothy M.
Yeap, Bu
Bruce, David G.
Davis, Wendy A.
DIABETES, 2007, 56 : A1 - A2
[22] Lipids, lipid-lowering therapy and diabetes complications
Valensi, P.
Picard, S.
DIABETES & METABOLISM, 2011, 37 (01) : 15 - 24
[23] Lipid lowering therapy in type 2 diabetes
Foeger, Bernhard
WIENER MEDIZINISCHE WOCHENSCHRIFT, 2011, 161 (11-12) : 289 - 296
[24] Improving cardiovascular risk - applying evidence-based medicine to glucose-lowering therapy with thiazolidinediones in patients with type 2 diabetes
Fisher, M.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (09) : 1354 - 1368
[25] Usefulness of aggressive lipid-lowering therapy with rosuvastatin in hypercholesterolemic patients with concomitant type 2 diabetes
Yutaka Mori
Genshin Kuriyama
Takaaki Tanaka
Naoko Tajima
Endocrine, 2009, 36 : 412 - 418
[26] Usefulness of aggressive lipid-lowering therapy with rosuvastatin in hypercholesterolemic patients with concomitant type 2 diabetes
Mori, Yutaka
Kuriyama, Genshin
Tanaka, Takaaki
Tajima, Naoko
ENDOCRINE, 2009, 36 (03) : 412 - 418
[27] The role of lipid-lowering therapy in preventing coronary heart disease in patients with type 2 diabetes
Karalis, Dean G.
CLINICAL CARDIOLOGY, 2008, 31 (06) : 241 - 248
[28] Effects of lipid-lowering therapy with fibrates on endothelial function in patients with type 2 diabetes mellitus
Watanabe, H
Nakagawa, K
Kakihana, M
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 210A - 210A
[29] Lipid-lowering therapy in the treatment of massive hard exudates in type 1 diabetes
Palarie, Natalia
Natalia, Palii
Tagadiuc, Olga
ACTA OPHTHALMOLOGICA, 2024, 102
[30] Socioeconomic factors, gender and adherence to lipid-lowering therapy in type 1 diabetes
Hero, C.
Karlsson, S. Axia
Franzen, S.
Svensson, A. -M.
Miftaraj, M.
Sundell, K. Andersson
Gudbjornsdottir, S.
Eliasson, B.
Eeg-Olofsson, K.
DIABETOLOGIA, 2018, 61 : S147 - S147

← 1 2 3 4 5 →